January 31, 2024

Blockbuster Biologics Review - Issue 22

Christopher Betti, Ph.d., Jennifer Patritti Cram, Ph.D, Margaret Harney, Maarika Kimbrell, Kelly Plummer, Ph.d.

Morgan Lewis

+ Follow Contact

Send

Embed

Welcome to the latest issue of Blockbuster Biologics Review, which covers the status and developments of post-grant challenges and patent litigations implicating blockbuster biologics and legislative proposals related to biosimilars in Q1 2024. We will continue to monitor developments in these post-grant challenges and litigations and provide you with regular updates.

Please see full publication below for more information.

View PDF

Download PDF [5975KB]

Report

LOADING PDF: If there are any problems, click here to download the file.

Send Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.